Gunnar Schulte is Professor in receptor pharmacology and research group leader for the section Receptor Biology and Signaling at the Department of Physiology and Pharmacology. He has a background in biochemistry from the Free University in Berlin/Germany and a PhD in molecular pharmacology (supervisor: Bertil B Fredholm) from Karolinska Institutet. As postdoc he trained first with Ernest Arenas (Karolinska Institutet, Molecular Neurobiology) and later with Roger J Summers (Monash University, Melbourna Australia, GPCR pharmacology) before starting his independent research team "Receptor Biology & Signalling". Gunnar Schulte is also the scientific secretary of the Swedish Society for Medical Research (SSMF) and member on the editorial board/editorial advisory board of Molecular Pharmacology, British Journal of Pharmacology, Pharmacological Reviews, and The Journal of Biological Chemistry.
Diploma (biochemistry) - Free University of Berlin, Germany (1992-1998)
PhD (Molecular Pharmacology) - Karolinska Institutet (1998-2002)
Postdoc (Molecular Neurobiology) - Karolinska Institutet (2003-2005)
Postdoc (Molecular Pharmacology - Monash University, Melbourna, Australia (2006)
Junior Researcher (Receptor Biology & Signaling) - Karolinska Institutet (2007-2014)
Senior Researcher (Receptor Biology & Signaling) - Karolinska Institutet (2015-2016)
Professor (Receptor Pharmacology - Karolinska Institutet (2017-)
General Research Interest: Frizzled signaling and pharmacology and the role of WNT/Frizzled signaling in biology, physiology and disease. Most importantly my research team tries to understand underlying mechanisms of WNT-receptor interaction, relevance of receptor dynamics and receptor complex composition and specification of downstream signaling. The ultimate aim is to use the new knowlegde to find and create Frizzled-targeting drugs to improve future therapies of human disease.